Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02738372
Other study ID # UMalaga
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 2016
Est. completion date March 2020

Study information

Verified date October 2018
Source University of Malaga
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Background: Shoulder pain is the third most common musculoskeletal condition presenting to physicians or physiotherapists ) in primary healthcare after low back and neck pain being a significant cause of morbidity and functional disability in both working and general population. Despite the large group of individuals seeking for primary care services, about 50% of patients with shoulder pain still report persistent pain after 12-18 months. As a result, socio-economic burdens are considerable due to extensive use of heath care services, sickness absence, disability pension, and loss of productivity as well as, patient´s suffering.

Aims: the primary aim of this study was to evaluate what biopsychosocial factors predict a better and/or poor outcome in patients with Chronic shoulder pain. The secondary aim was to analyze the role of central sensitization in predicting a better and/or poor outcome in patients with Chronic shoulder pain.

Hypothesis:

1. A high level of physical inactivity, kinesiophobia, fear avoidance and pain catastrophizing and low level of self-efficacy will ease the perpetuation of Chronic shoulder pain.

2. The presence of central sensitization will predict a poor outcome in patients with chronic shoulder pain.


Description:

The present study will be a 24 months multi-center, double-blind, prospective, cohort study which will be carried out between April 2016 and March 2018. Subjects diagnosed of rotator cuff (RC) tendinopathy, adhesive capsulitis (AC), glenohumeral instability, superior labrum anterior to posterior (SLAP) lesion, and/or acromioclavicular pathology and fulfill the inclusion criteria will be asked for participating in the investigators study. Several questionnaires that will test the influence of different biopsychosocial factors and the presence of Central Sensitization will be administrated to these subjects. The outcomes will be assessed at baseline and 5 follow-ups (after 3, 6, 12, 18 and 24 months, t1-t6).

Subjects will attend for their routine clinical appointment. The examiners will carry out the clinical consultation according to usual practice. Subjects who fulfill the selection criteria will be asked whether they wish to be considered for trial participation. Examiners will inform subjects who are interested in participation. Ineligible subjects and those who do not wish to participate in the trial will receive normal clinical care delivered by clinicians according to the best clinical practice.

Anonymized age, gender and visual analogue scale (VAS)- verbal numeric rating scale (VNRS) for pain will be collected for those subjects who decline to take part in the project, in order to assess the external validity of the recruited sample of subjects.

Eligible patients who are interested in the trial will be asked to provide written informed consent to participate. The examiners will allocate the participants in an unique study group. Participants will then complete several questionnaires at baseline, 3, 6, 12, 18 and 24 months after the beginning of the study. A blinded examiner will deliver these questionnaires. Subsequent sessions will occur at the follow-up visits. Participants will be asked about any problems they had had during the previous months before following-up. There will be brief discussion about whether participants have subjected for any treatment (physical, pharmacological, injection and/or no treatment).


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date March 2020
Est. primary completion date November 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

1. Men / women aged between 18 and 70 years.

2. Patients suffering from shoulder pain, defined as pain presented or exacerbated by movements in the shoulder, pain intensity = 2 measured by a numerical scale with values from 0 to 10, meaning 0= no pain and 10= the worst pain, will be included in this study, among all these following shoulder pain conditions: (i) rotator cuff (RC) tendinopathy ; (ii) adhesive capsulitis (AC) ; (iii) glenohumeral instability ; (iv) SLAP lesion; (v) and/or acromioclavicular pathology. Subjects will not be required to undergo diagnostic imaging (i.e MRI) to diagnosis the pathology because of the recruitment will be carried out by clinical findings.

3. Duration of symptoms: greater than 3 months.

Exclusion Criteria:

1. Recent shoulder dislocation (1 year prior) and/or systemic diseases such as rheumatoid arthritis, osteoarthritis, fibromyalgia and/or polymyalgia rheumatica.

2. Shoulder pain considered to be originated in the cervical region and other traumas or if there is a neurological dysfunction (i.e multiple sclerosis), osteoporosis, hemophilia and / or cancer.

3. Inability to provide informed consent and/or complete written questionnaires.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Diagnosis/Prognosis
The present study will be a 24 months multi-center, triple-blind, prospective, cohort study which will be carried out between April 2016 and March 2018. Subjects diagnosed of rotator cuff (RC) tendinopathy, adhesive capsulitis (AC), glenohumeral instability, SLAP lesion, and/or acromioclavicular pathology and fulfill the inclusion criteria will be asked for participating in our study. Several questionnaires that will test the influence of different biopsychosocial factors and the presence of Central Sensitization will be administrated to these subjects. The outcomes will be assessed at baseline and 5 follow-ups (after 3, 6, 12, 18 and 24 months, t1-t6).

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Malaga

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline The brief pain inventory short form (BIP-SF) at 3,6,12,18 and 24 months Pain will be assessed with The brief pain inventory short form (BIP-SF). This will be used to assess how pain interferes with patient's functioning in addition to measuring the intensity and location of pain. Pain will be evaluated at baseline and 5 follow-ups (3,6,12,18 and 24 months).
Secondary Change from baseline Pain catastrophizing at 3, 6, 12, 18 and 24 months assessed with The Pain Catastrophizing Scale (PSC) The catastrophic thinking bout pain will be assessed with The Pain Catastrophizing Scale (PSC). Pain catastrophizing will be evaluated at baseline and 5 follow-ups (3,6,12,18 and 24 months).
Secondary Change from baseline Kinesiophobia at 3,6,12,18 and 24 months assessed with Tampa Scale For Kinesiophobia (TSK) The fear of movement (kinesiophobia) will be assessed with Tampa Scale For Kinesiophobia (TSK). Kinesiophobia will be evaluated at baseline and 5 follow-ups (3,6,12,18 and 24 months).
Secondary Change from baseline Fear avoidance at 3,6,12,18 and 24 months assessed with Fear Avoidance Belief Questionnaire (FABQ) Fear avoidance will be assessed with Fear Avoidance Belief Questionnaire (FABQ). Fear avoidance will be measured at baseline at 5 follow-ups (3,6,12,18 and 24 months)
Secondary Change from baseline Self-efficacy at 3,6,12,18 and 24 months assessed with Pain Self-Efficacy Questionnaire (PSEQ) Self-efficacy will be assessed with Pain Self-Efficacy Questionnaire (PSEQ) Self-efficacy will be measured at baseline at 5 follo-ups (3,6,12,18 and 24 months)
Secondary Change from baseline Shoulder Function at 3,6,12,18 and 24 months assessed with Shoulder Pain and Disability Index (SPADI) Function will be assessed with Shoulder Pain and Disability Index (SPADI) Function will be measured at baseline and 5 follow-ups (3,6,12,18 and 24 months)
See also
  Status Clinical Trial Phase
Completed NCT01289236 - "MILNACIPRAN" in Subjects With Chronic Shoulder Pain Phase 4
Completed NCT05137106 - Assessment of Effectiveness of Dry Needling for Treating Shoulder Pain N/A
Withdrawn NCT05364099 - Suprascapular Nerve Block for Treatment of Shoulder Pain in Individuals With Spinal Cord Injuries Phase 4
Not yet recruiting NCT03739021 - Exparel for Total Shoulder Pain Phase 2/Phase 3
Not yet recruiting NCT04245969 - Efficacy of 448kilohertz Capacitive Resistive Monopolar Radiofrequency Stimulation in Chronic Shoulder Pain N/A
Completed NCT04316793 - Effects of Dry Needling When Applied to the Infraspinatus Muscle in People With Chronic Shoulder Pain N/A
Completed NCT03000205 - Effects of Hypertonic Dextrose Water Injection for Supraspinatus Tendinosis Patients N/A
Recruiting NCT05754190 - Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
Completed NCT05072899 - Platelet Rich Plasm Versus Hyaluronic Acid Injection in Chronic Painful Shoulder N/A
Recruiting NCT04916353 - Effects of Ultrasound-guide Hypertonic Dextrose Injection for Chronic Subacromial Bursitis N/A
Recruiting NCT04938037 - Comparison of the Efficacy of Two Different Suprascapular Nerve Block Techniques in Patients With Chronic Shoulder Pain N/A
Recruiting NCT05481710 - Nociplastic Pain in Patients With Chronic Shoulder Pain
Completed NCT05829707 - Long-term Outcomes of Breast Cancer Patients After Wound Infiltration Analgesia Phase 4
Completed NCT06135038 - Injection in Patients With Chronic Shoulder Pain N/A
Recruiting NCT04737993 - Pulsed Radiofrequency of Suprascapular Nerve and Shoulder Joint for Chronic Shoulder Pain N/A
Completed NCT04475965 - The Effectiveness of Isometric Exercise on the Management of Chronic Shoulder Pain N/A
Completed NCT03838471 - Cognitive Behavioral Factors and Central Sensitization in Chronic Shoulder Pain
Recruiting NCT04954391 - Pulsed Radiofrequency One or Three Nerves for Chronic Shoulder Pain. A Prospective, Randomized, Double-blind Study N/A
Completed NCT04636528 - Digital Versus Conventional Physical Therapy for Chronic Shoulder Tendinopathy N/A
Terminated NCT04077164 - Chronic Pain, Couples, & Physical Activity